Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Conexeu Sciences Inc. (CNXU) commenced trading on Nasdaq on May 21, 2026, as a regenerative tissue platform company. The company's proprietary CXU™ extracellular matrix platform is designed to scale across multiple markets including wound care, breast reconstruction, and aesthetic medicine without reformulation. The company targets a 510(k) submission in early 2027 and holds issued patents across major markets with no royalty obligations.

05/22/2026, 10:31 AM • Benzinga

Integra LifeSciences Reports First Quarter 2026 Financial Results

Integra LifeSciences reported Q1 2026 revenues of $391.9 million (up 2.4% reported, 1.3% organic) with improved gross margins and adjusted EPS of $0.54 versus $0.41 year-over-year. The company reaffirmed full-year revenue guidance of $1.662-$1.702 billion and raised adjusted EPS guidance to $2.40-$2.50 from $2.30-$2.40. Stuart Essig was appointed as the new President and CEO, and the company highlighted progress in manufacturing operations and product relaunches.

05/05/2026, 6:00 AM • GlobeNewswire

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence

The global tissue engineering market is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, driven by advancements in regenerative medicine, biomaterials, and stem cell research. Key growth drivers include increasing demand for regenerative therapies, innovations in 3D bioprinting, rising prevalence of chronic diseases, and expanding applications in orthopedics, skin regeneration, and dental restoration. North America leads the market while Asia-Pacific emerges as a high-growth region.

04/24/2026, 3:54 AM • GlobeNewswire

[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global advanced wound closure market is projected to grow from USD 18.47 billion in 2025 to USD 32.54 billion by 2035, at a CAGR of 6.9%. Growth is driven by increasing surgical procedures, rising chronic wounds and diabetes cases, and technological innovations in surgical sealants, hemostats, and tissue adhesives. North America leads the market while Asia Pacific shows the highest growth potential.

02/02/2026, 2:30 PM • GlobeNewswire

Orthopedic Implants Market Outlook 2025–2034

The global orthopedic implants market is valued at USD 52.86 billion in 2026 and is expected to reach USD 80.14 billion by 2034, growing at a 5.34% CAGR. North America leads the market while Asia-Pacific is the fastest-growing region. Joint reconstruction dominates by product type, with spinal implants showing significant growth potential. Key drivers include an aging population, rising musculoskeletal disorders, and technological innovations in 3D-printed and AI-enabled implants.

01/30/2026, 10:00 AM • GlobeNewswire

Integra LifeSciences Reports Third Quarter 2025 Financial Results

Integra LifeSciences reported Q3 2025 revenues of $402.1 million, a 5.6% increase from the previous year. The company saw healthy demand across its portfolio, with strong profitability driven by disciplined cost management and operational efficiencies.

10/30/2025, 6:00 AM • GlobeNewswire

United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio

The US breast reconstruction market is projected to grow from $1.02 billion in 2024 to $1.74 billion by 2033, driven by rising breast cancer incidences, improved surgical techniques, and increased insurance coverage.

10/23/2025, 4:52 AM • GlobeNewswire

Craniomaxillofacial Devices Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034

The global craniomaxillofacial devices market is projected to grow from $1.8 billion in 2024 to $3.9 billion by 2034, driven by increased facial injuries, technological advancements, and minimally invasive surgical techniques.

09/25/2025, 4:44 AM • GlobeNewswire